Effect of plaque brachytherapy dose and dose rate on risk for disease-related mortality in 1238 patients with choroidal melanoma

Maria Filì, Eric Trocme, Christina Herrspiegel, Stefan Seregard, Gustav Stålhammar

Read More

Effects of plaque brachytherapy and proton beam radiotherapy on prognostic testing: a comparison of uveal melanoma genotyped by microsatellite analysis

Sophie Thornton, Sarah E Coupland, Heinrich Heimann, Rumana Hussain, Carl Groenewald, Andrzej Kacperek, Bertil Damato, Azzam Taktak, Antonio Eleuteri, Helen Kalirai

Read More

 

Practice Patterns for the Treatment of Uveal Melanoma with Iodine-125 Plaque Brachytherapy: Ocular Oncology Study Consortium Report 5

Binder C. · Mruthyunjaya P. · Schefler A.C. · Seider M.I. · Crilly R. · Hung A. · Meltsner S. · Mowery Y. · Kirsch D.G. · Teh B.S. · Jennelle R.L.S. · Studenski M.T. · Liu W. · Lee C. · Hayman J.A. · Kastner B. · Hadsell M. · Skalet A.H. · Ocular Oncology Study Consortium

Read More

Nomogram for visual acuity outcome after iodine-125 plaque radiotherapy and prophylactic intravitreal bevacizumab for uveal melanoma in 1131 patients

Lauren A Dalvin, Qiang Zhang, Rose A Hamershock, Michael Chang, Michael D Yu, Arman Mashayekhi, Carol L Shields

Read More

The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma

Lee M. Jampol, Claudia S. Moy, Timothy G. Murray, Sandra M. Reynolds, Daniel M. Albert, Andrew P. Schachat, Kenneth R. Diddie, Robert E. Engstrom Jr., Paul T. Finger, Kenneth R. Hovland, Leonard Joffe, Karl R. Olsen, Craig G. Wells for the COMS Follow-up of Plaqued Eyes Working Group

Read More

Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma

Carol L. Shields, MD; Lauren A. Dalvin, MD; Michael Chang, MD; Mehdi Mazloumi, MD, MPH; Patricia Fortin, BA; Mark McGarrey, BS; Andrei Martin, MD; Antonio Yaghy, MD; Xiaolu Yang, MD, Ph1; Pornpattana Vichitvejpaisal, MD; Arman Mashayekhi, MD; Jerry A. Shields, MD

Read More

https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2756338

 

 

COMMENTARY:

Culver Boldt, MD; Timothy G. Murray, MD, MBA; Elaine M. Binkley, MD

Read More

https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2756334

 

Intraocular Metastasis in Unilateral Multifocal Uveal Melanoma Without Melanocytosis or Germline BAP1 Mutations

Michael A. Durante, BS; Scott D. Walter, MD, MSc; Manuel Paez-Escamilla, MD: Julian Tokarev, MD; Christina L. Decatur, BS; Sander R. Dubovy, MD; Amy C. Schefler, MD4; J. William Harbour, MD

Read More

https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2752218

Comparison between patient-reported outcomes after enucleation and proton beam radiotherapy for uveal melanomas: a 2-year cohort study

Laura Hope-Stone, Stephen L. Brown, Heinrich Heimann & Bertil Damato

Read More

https://www.nature.com/articles/s41433-019-0440-0

Intravitreal aflibercept for the treatment of radiation-induced macular edema after ruthenium 106 plaque radiotherapy for choroidal melanoma

Matteo Fallico, Michele Reibaldi, Teresio Avitabile, Antonio Longo, Vincenza Bonfiglio, Argyrios Chronopoulos, Rosario Caltabiano, Corrado Spatola, Andrea Russo

Read More

https://link.springer.com/article/10.1007/s00417-019-04347-6

Prior non-irradiative focal therapies do not compromise the efficacy of delayed episcleral plaque brachytherapy in retinoblastoma

John T Lucas, Rose McGee, Catherine A Billups, Ibrahim Qaddoumi, Thomas E Merchant, Rachel C Brennan, Jiangrong Wu, Matthew W Wilson

Read More

https://bjo.bmj.com/content/103/5/699

1 2 3